Latest filing published 16 Aug 2012 for RESPONSE GENETICS INC, €1,825.
No signal scores available.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lansdowne Partners Limited Partnership discloses dealings in Response Genetics Inc to SEC (Form 4). Between 5 March 2010 and 14 August 2012, the trades on record add up to 9 filings.
The open-market side counts 2 purchases for €919k alongside 7 sales for €106k. The net balance comes to €813k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2012 to date brings no purchases and 7 sales.
The record was last updated on 16 August 2012 with an open-market sale (€1,825) in Response Genetics Inc. The latest purchase dates back some time: it was published 5,646 days ago, on 10 May 2011. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations